Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

142.01
+9.407.08%
Volume:551.35K
Turnover:77.09M
Market Cap:6.34B
PE:-14.57
High:142.57
Open:133.35
Low:133.31
Close:132.61
52wk High:166.48
52wk Low:41.50
Shares:44.67M
Float Shares:40.73M
Volume Ratio:0.49
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.7487
EPS(LYR):-11.1105
ROE:-16.12%
ROA:-12.03%
PB:2.49
PE(LYR):-12.78

Loading ...

Grail Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

THOMSON REUTERS
·
Aug 07

Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)

TIPRANKS
·
Aug 06

Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and SanDisk Corp (SNDK)

TIPRANKS
·
Aug 06

Grail Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

GRAIL Q2 EPS $(2.56) Beats $(2.62) Estimate, Sales $44.687M Beat $42.760M Estimate

Benzinga Earnings
·
Aug 06

Grail Q2 Revenue Rises 26%, Net Loss Narrows 3%

Reuters
·
Aug 06

Grail Inc Q2 Net Income USD -110.247 Million

THOMSON REUTERS
·
Aug 06

Grail Inc Expected to Post a Loss of $2.65 a Share - Earnings Preview

Reuters
·
Aug 04

Grail Management to Present at Canaccord Genuity Growth Conference

Reuters
·
Jul 31

Grail to Report Q2 2026 Results After Market Close, Host Webcast Call

Reuters
·
Jul 30

Priority Health Collaborates with Grail as the First Michigan Health Plan to Offer the Galleri® Multi-cancer Early Detection Blood Test to Employer Plans

THOMSON REUTERS
·
Jul 16

Grail Inc : Mizuho Raises Target Price to $65 from $58

THOMSON REUTERS
·
Jul 15

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

Dow Jones
·
Jul 10

GRAIL (GRAL) Could Be 5% Overvalued Following Trial Miss And Class Actions

Simply Wall St.
·
Jul 07

When Multi-cancer Blood Screens Could Finally Take Off

Dow Jones
·
Jul 02

Grail Partners with Samsung C&T to Commercialize Galleri Cancer Test in South Korea

Reuters
·
Jun 25

Grail Rises as $110 Mln Samsung-backed Funding Boosts Cancer Test Expansion

Reuters
·
Jun 25

Grail Closes USD 110 Million Equity Financing with Samsung Affiliates at USD 70.05 a Share

Reuters
·
Jun 25

Grail Completes $110 Million Equity Financing with Samsung Entities

THOMSON REUTERS
·
Jun 25

Press Release: GRAIL Completes $110 Million Equity Financing with Samsung Entities

Dow Jones
·
Jun 25